The ALOX12B gene helps the outer layer of skin form a strong barrier that holds in moisture and keeps irritants out. If this gene does not work properly, the skin barrier may not develop as it should, which can lead to very dry, scaly, red, or cracked skin. Pathogenic variants in the ALOX12B gene are linked to inherited forms of ichthyosis, a skin condition that affects how skin cells mature and shed. Some babies are born with a tight, shiny membrane over the skin, and symptoms may become milder over time in some people.
What is a gene?
A gene is a stretch of DNA that holds instructions cells use to make molecules or guide processes in the body. Some genes provide the directions for producing proteins, which are the parts of cells that do much of the work. Others are mainly involved in regulating when certain processes happen, where they take place, and how active they are. Taken together, genes affect how the body grows and works, and they can also influence how you respond to food, stress, and medications. More detailed information on this topic is available in the LearnHub.
Overview
ALOX12BGene function
What if the gene works
The ALOX12B gene helps your skin build and maintain its outer barrier. Its protein processes skin fats that support normal shedding and help keep moisture in while blocking irritants and germs out.
Risk
What if the gene does not work
When the ALOX12B gene does not work properly, skin barrier formation is impaired, causing autosomal recessive congenital ichthyosis. People may be born with shiny skin and develop dry, scaly skin, with effects ranging from self improving to more persistent.
Treatment
What does that mean for your treatment
No ALOX12B-specific treatment or management approach is currently established. If you carry a pathogenic variant in the ALOX12B gene, treatment is usually guided by skin symptoms and standard ichthyosis care, not by a gene-specific drug choice.
Conditions associated with ALOX12B
Gene function
What if the gene works
Healthy skin depends on a well-built outer barrier that keeps water in and everyday irritants out. In your skin, the ALOX12B gene helps prepare specific fats that become part of this barrier. Its activity is strongest in the upper layers, where skin cells are finishing their normal maturation.
The ALOX12B gene helps skin cells change certain fats into forms used in the outer skin layer. This is an early step in making lipids that support healthy skin barrier function.
Its protein works with other skin enzymes to organize protective fats between surface cells. This helps the outer layer hold moisture in and limit entry of irritants from the environment.
During normal skin renewal, the ALOX12B gene supports the final maturation of cells as they move toward the surface. These mature cells, together with processed fats, form a flexible outer covering.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and help shape normal differences between people, such as appearance, metabolism, or the way the body reacts to environmental influences. Many variants do not cause any noticeable effect and are simply part of natural genetic variation. At times, though, a variant can change how a gene works to a greater extent and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
How ALOX12B gene variants affect the skin barrier depends on whether the change makes the protein fold poorly, become unstable, or lose enzyme activity. More disruptive variants, including changes that cut the protein short, usually cause a larger loss of function, while some single-letter changes leave partial activity. This functional range can influence autosomal recessive congenital ichthyosis, with less residual activity often linked to earlier or more persistent scaling.
How variants are linked to conditions
Pathogenic variants in the ALOX12B gene cause autosomal recessive congenital ichthyosis, a group of conditions marked by dry, thick, scaly skin from birth or early infancy. Variants in the ALOX12B gene are especially linked to collodion baby presentations at birth and later skin findings such as lamellar ichthyosis or congenital ichthyosiform erythroderma. Severity varies, and some people improve after the newborn period while others continue to have lifelong scaling and redness.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are widely found in the general population. Most do not have a direct effect on health and simply contribute to natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a confirmed diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For ALOX12B, risk is mainly set by the variants inherited at birth rather than by lifestyle or everyday exposures. If both biological parents carry a harmful ALOX12B variant, each pregnancy has a 25% chance of being affected; dry air, heat, and skin irritation can worsen symptoms, but they do not change the inherited genetic risk.
Inheritance of ALOX12B variants
For families looking into the ALOX12B inheritance pattern, disease-causing variants in the ALOX12B gene are inherited in an autosomal recessive way. This means a child usually inherits one variant from each parent. Parents who each carry one ALOX12B variant are often unaffected themselves, and with each pregnancy there is a 25% chance the child will inherit both variants, a 50% chance the child will be a carrier, and a 25% chance the child will inherit neither variant. This pattern applies to the well-established skin conditions linked to the ALOX12B gene.
What does my ALOX12B result mean for my family?
For ALOX12B, family implications are usually tied to a recessive skin condition that can cause very dry, scaly skin from birth. Parents of an affected child are often healthy carriers, and brothers or sisters may also be affected or be carriers. Other close relatives may carry the same gene change, especially on the side of the family it came from.
Genetic information
Genetic testing
How you find out about variants
Variants in the ALOX12B gene are usually found with genetic testing for ALOX12B variants, using blood, saliva, or a cheek swab. A lab reads the DNA in this gene and compares it with the usual pattern to look for changes. Results may show a benign variant, a disease causing variant, or a change that is still unclear.
When should I consider getting a genetic test?
Consider ALOX12B testing when a baby is born with tight, shiny skin, widespread scaling, or ongoing red, fragile skin that suggests an inherited skin condition. It can also help when this kind of skin condition runs in the family or when both parents are known carriers.
A genetic result is only one part of your health story
A genetic result can be informative, but what it tells you depends on the condition in question and the type of variant involved. Over time, age, lifestyle, environment, and medical history also influence how the body works. For some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down a drug, moves it through the body, or responds to it at its target. This helps explain why the same treatment works well for one person, has less effect in another, or causes more side effects in someone else. These differences are common and can influence both how well a medicine works and how sensitive a person may be to it.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes can affect the way they respond to medications. It studies gene drug relationships to help explain why the same treatment may work differently in different people. For many medicines, genes can influence how the body handles a drug or how strong its effects are. This information can support treatment decisions that are more informed and more personalized. More detail on this topic is available in the LearnHub.
Drugs influenced by the ALOX12B gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines will work, so questions about treatments, side effects, or changes in how you feel are best discussed with your doctor.
History
Researchers identified the ALOX12B gene in the late 1990s as part of a group of skin related lipoxygenase genes. From these first observations, research expanded steadily. In the early 2000s, studies linked variants in the ALOX12B gene to some forms of autosomal recessive congenital ichthyosis, helping explain why certain families had long standing inherited skin findings. This work was part of a broader period when scientists were sorting out the genetic causes of rare conditions affecting the skin barrier. Over time, descriptions became more precise, and the ALOX12B gene became recognized as one of the established genes included in ichthyosis genetics and diagnostic testing.